Spectral Medical announced that Health Canada has issued an Interim Order expanding the approved indications for use of Spectral’s Toraymyxin™ hemoperfusion cartridge for patients with COVID-19
Toraymyxin® is a treatment for patients with endotoxic septic shock who are unresponsive to conventional therapies.
The Interim Order allows the use of PMX to treat COVID-19 patients, particularly those with respiratory difficulties, in the presence of low blood pressure due to endotoxemia.
Toraymyxin has been used in this and previous viral pandemics [H1N1] and showed improvement in chest x-ray results and lung function, and successful wean from mechanical ventilation.